C7 Flashcards

1
Q

Explain protein & diseases

A
  • Arise due abnormal protein
  • Can be diagnose or treated at DNA, RNA or proteins levels
  • At each stage, disease related protein can potentially act as biomarker & therapeutic target
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Various role of protein & their potential for manipulation such as

A
  • Initiation of diseases
  • Development of diseases
  • Outcome of disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain cystic fibrosis

A
  • caused by changes in ion channel
  • Unable to regulate Cl ion movement
  • Cause thick, sticky mucous that affect lungs
  • cause bone problem & mobility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Symptoms of cystic fibrosis

A
  • Bad cough
  • Repeat chest infection
  • Diarrhoea
  • Poor weight gain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain cystic fibrosis gene

A
  • 3 bp deletion that lead to Del580
  • 27 exon
  • CFTR: 1440 amino acid
  • 2 ATP binding cassettes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Effects of Cl- ion movement

A
  • Na constantly pump out of cell
  • Flow of Cl out of cell provide counter ion effect
  • Allow graduent of NaCl to build up
  • Water move from blood vessel to epithelial in response to NaCl gradient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happen to ion movement if CFTR gene defective

A
  • Water movement inhibited
  • Produce thick mucus
  • Effect lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Example of drug for cystic fibrosis

A
  • Genistein
  • Phenylbutyrate
  • Osmolites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain protein misfolding disease

A
  • Not involve changes in genome
  • Group of diseases share the same pathophysiology
  • Arise from normal protein in body that undergo changes in shapes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Example of protein misfolding disease

A
  • Transmissible spongiform encephalopathies (TSE)
  • Alzheimer
  • Parkinson
  • Type 2 diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathophysiology of protein misfolding disease

A
  • Abnormal protein
  • Aggregates
  • Froms amyloids
  • Plague
  • Holes
  • Sponge
  • Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain TSE

A
  • Involve formation of plaque & holes in brain
  • Loss of control, dementia & death
  • Cause by prions (proteninaceous infectious agent)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Types of TSE

A
  • Scarpie: sheep
  • BSE & Mad cow: cow
  • Kuru & CJD: Human
  • CJD, GSS & Fatal Familial insomnia: Familial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain prion

A
  • Named as PrP (prion protein)
  • Size in 27-30 kDa
  • Found in normal cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Difference between PrPc & PrPSc

A

PrPc
- Normal prion
- On surface of neurons
- Bind to Cu ions
- Digested by proteinase K

PrPSc
- Abnormal prion
- Aggregate to form structure amyloid fibres
- Accumulate to from plaque
- Protease resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How PrPSc convert all PrPc to abnormal

A
  • Infection with PrPSc convert normal PrP from contaminated brain products or surgery tools
  • PrPSc resistant to autoclave
  • Denature PrPSc can renature
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain Alzheimer disease

A
  • Cause by abnormalities of amyloid beta & Tau protein
  • Coded by APP gene
  • Crucial for neuron growth, survival & repair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mechanism of Alzheimer disease

A
  • APP cut into smaller amyloid beta peptide which form amyloid plaques
  • Tau become hyperphosphorylated which aggregate to lead to brain shrinkage
19
Q

Explain parkinson disease

A
  • Protein a-synuclein - unknwon function
  • Exist as membrane bound a helices in cytoplasm
  • Change shape to b sheet like oligomer & aggregate into fibrils and to Lewis bodies
20
Q

Explain type 2 diabetes

A
  • Amylin - islet amyloid polypeptide
  • Produce by beta cell in pancreas
  • Hormone that acts in glycemic control (role of insulin)
  • Aggregate into fibrils & kill beta cell
  • Cause diabetes
21
Q

Possible therapy for protein misfolding disease

A
  • Re-chaperoning
  • Use small molecule to stabilise protein in correct form
22
Q

Diseases development occur due to

A
  • Accumulation of abnormal protein
  • Action of subsequent abnormal protein
23
Q

Action of subsequent abnormal protein include

A
  • Cell escape from original sites
  • Protection against immune system
  • Mediating metastasis
24
Q

Example of abnormal expression

A

MUC1 in breast cancer
- Glycoprotein of MUC1 abnormally expresedd
- Normally, cell adhere to each other & line on basal membrane
- Charged glycan on MUC1 form protective shield for the cell
- Abnormal will prevent cell adherence, charge glycan MUC1 repel each other & escape to metastasis

Her-2/neu In breast cancer
- Is a growth factor receptor that bind to growth factor to start cell proliferation
- Breast cancer cell over expressed to bind with excess growth factor
- Cause hyper proliferation & metastasis

25
Function of abnormal protein as therapeutic target
Aim to destroy function of disease related protein & improve or cure diseases
26
Explain protein for screening & diagnosis
- Majority of disease marker is protein - Protein marker more reliable the closer they are to site of disease
27
Why tissue sample or other sample not use as biomarker
- Too complex for analyis - Screening require biopsy - Some are difficult to obtain in sufficient amounts
28
Example of protein biomarker
- Prostate specific antigen (PSA) - MUC1 glycoprotein - Her-2/neu protein
29
What is the most accurate marker to date
Prostate specific antigen (PSA)
30
Biomarkers measure from patient to indicate
- Stage of disease - Disease or healthy - Response to treatment - Best therapy option
31
Define biomarker
A characteristic that objectively measure & evaluated as indicator of normal biological process, pathogenic or pharmacological response to therapeutic intervention
32
Explain biomarker
- Indicator of particular disease of a patient - Individual marker, lanel of marker, signature
33
Pros of biomarker
- Minimally invasive - Cheap & quick - Secreted by disease tissue only - Highly sensitive - Highly specific
34
Define specificity of biomarker
- Percentage of people who test negative for specific disease among group of people dont have the disease - No test is 100% specific because some people dont have the disease will test positive (false positive)
35
Explain sensitivity in biomarker
- Percentage of people who test positive for specific disease among group who have the disease - No test has 100% sensitivity because some people who have the disease test negative (false negative)
36
5 types of biomarker
- Translation - Disease - Toxicity - Efficacy - Target
37
Explain protein as biomarker
- Better markers than genes - Most cancer marker are protein - Drug target protein - Common across diseases
38
Explain proteomics to mine biomarker
- Find a disease by looking for changes in protein profile of tissue - Promising for early diagnosis & monitoring prognosis of cancer - Use 2D gel & MS
39
Example of tumor associated biomarker
- PSA - Monoclonal protein - AFP - Beta HCG
40
Steps to find biomarker
- Discovery: select sample for comparison - Identify candidates biomarker using 2D or MS - Select panel of potential biomarker - Qualification of biomarker panel - Verification & validation - Develop clinical test based on validated biomarker
41
Steps for biomarker validation
- Retrospective study: compare diseases & non disease - Prospective study: ability to detect disease before become clinically apparent - Prospective sceering study - Randomise clinical trial
42
Challenges in biomarker discovery
- Sensitive enough to avoid false negative - Safe for consumption - Reproducible
43
Why validation of biomarker difficult
- Disease phenotype vary - Large sample size - Phenotype affected by age, sex - Lack of standards
44
Form of validation
- Biomarker validation - Assay validation